Twenty‐year trends in benzodiazepine dispensing in the Australian population
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Aim: Considerable concern has been expressed about overprescribing of benzodiazepines and related harms. Past analyses have relied on W orld H ealth O rganization‐defined daily doses (DDD) which are sometimes out of keeping with clinical usage. This study examines 20‐year (1992–2011) trends of benzodiazepine dispensing in A ustralia using both DDD and A shton equivalent dose. Methods: Data from the D rug U tilisation S ub‐C ommittee and the P harmaceutical B enefits S cheme (PBS) website were analysed. Trends in number of prescriptions, DDD/1000 people/day and DDD/prescription were examined over time, and between states/territories. Results: In the 20‐year period, 174 080 904 scripts were recorded, with temazepam the most dispensed benzodiazepine (35% of scripts), followed by diazepam (23%). Overall recorded utilisation fell from 27.7 DDD/1000 people/day in 1992 to 20.8 in 2011 (24.9% decrease). There were striking changes in use of individual benzodiazepines over time, with reductions in oxazepam and flunitrazepam and dramatic increases in alprazolam. Since 1998, there has been a steady increase, albeit modest, in per script DDD. The DDD/1000 people/day for items dispensed through PBS/R epatriaton‐PBS was highest in T asmania and lowest in N orthern T erritory. Conclusion: Despite a modest overall decline in the amount of benzodiazepine dispensed, the level of use is still likely to reflect relative over‐prescribing given the paucity of accepted indications for long‐term use. Since 1998, there was a polynomial increase in quantity dispensed per script. The WHO‐defined DDD for clonazepam seems inappropriate and could impede monitoring of its abuse. Other problems include lack of national data for medications not subsidised on PBS/R epatriation PBS. A broad policy approach is required, not one which targets only one particular benzodiazepine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive Effects of Long-Term Benzodiazepine Use: A Meta-Analysis
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00004 · Cited by 552
Withdrawing Benzodiazepines in Primary Care
Lader, M., Tylee, A., & Donoghue, J. (2009) · CNS Drugs · doi:10.2165/0023210-200923010-00002 · Cited by 318
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217
Strategies for discontinuing long-term benzodiazepine use: Meta-analysis
Voshaar, R. C. O., Couvée, J. E., Van Balkom, A. J. L. M., Mulder, P. G. H., & Zitman, F. G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.189.3.213 · Cited by 205
Benzodiazepines and Injurious Falls in Community Dwelling Elders
Pariente, A., Dartigues, J.-F., Benichou, J., Letenneur, L., Moore, N., & Fourrier-Réglat, A. (2008) · Drugs & Aging · doi:10.2165/00002512-200825010-00007 · Cited by 172
Current use of benzodiazepines in anxiety disorders
Cloos, J.-M., & Ferreira, V. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32831a473d · Cited by 127
Ashton, H. (2004) · Adverse Syndromes and Psychiatric Drugs · doi:10.1093/med/9780198527480.003.0013 · Cited by 25
Cited by
Kurko, T. A. T., Saastamoinen, L. K., Tähkäpää, S., Tuulio-Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M. S., & Hietala, J. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.09.003 · Cited by 280
Management of benzodiazepine misuse and dependence
Brett, J., & Murnion, B. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.055 · Cited by 260
Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2257-8 · Cited by 192
Nielsen, S., Lintzeris, N., Bruno, R., Campbell, G., Larance, B., Hall, W., Hoban, B., Cohen, M. L., & Degenhardt, L. (2015) · Pain Medicine · doi:10.1111/pme.12594 · Cited by 131
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Baandrup, L., Ebdrup, B. H., Rasmussen, J. Ø., Lindschou, J., Gluud, C., & Glenthøj, B. Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011481.pub2 · Cited by 128
The reappraisal of benzodiazepines in the treatment of anxiety and related disorders
Starcevic, V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.963057 · Cited by 90
“The pattern of prescribing or using BDZs in England from 1998 to 2010, in Australia between 2000 and 2011, and in The Netherlands from 1992 to 2002 (among people aged 55–64) was generally stable [15–17].”
BackgroundResultInfluentialStories of Hell and Healing: Internet Users’ Construction of Benzodiazepine Distress and Withdrawal
Fixsen, A. M., & Ridge, D. (2017) · Qualitative Health Research · doi:10.1177/1049732317728053 · Cited by 34
Brandt, J., Alkabanni, W., Alessi-Severini, S., & Leong, C. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0648-y · Cited by 27
Motivational drive and alprazolam misuse: A recipe for aggression?
Albrecht, B., Staiger, P. K., Hall, K., Kambouropoulos, N., & Best, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.040 · Cited by 10
“It is notable that such patterns of use aligns with Australian data showing alprazolam and diazepam to be among the most widely prescribed (Islam et al., 2014) and misused (Nielsen et al., 2008; Stafford & Burns, 2012) benzodiazepines, and also the most widely studied in relation to exploring the…”
Metadata
- Authors
- Islam, M. M., Conigrave, K. M., Day, C. A., Nguyen, Y., & Haber, P. S.
- Venue
- Internal Medicine Journal
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 44
- Issue
- 1
- Pages
- 57-64
- ISSN
- 1444-0903 (ISSN-L)
- 1445-5994
- OpenAlex
- W2120830237
- Cited by
- 73
- References
- 7
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.